Join
Live feed
·
PRReleasevia Quantisnow
Urovant Sciences Ltd. logo

Sumitovant Biopharma Completes Acquisition of Urovant Sciences Sumitovant Biopharma

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track UROV (Urovant Sciences Ltd.) and more on Quantisnow.